Brought to you by 
J&J merging biopsy device company Biopsys for $310mm
13 Jul 1999
Executive Summary
J&J agreed to a stock-for-stock merger of Biopsys Medical, valuing Biopsys at $27.55 per share (each Biopsys share converts to 0.439 J&J share), or about $310mm. The company makes products for minimally invasive breast biopsies for cancer diagnosis.
Deal Industry
- Medical Devices
-
Medical Devices
- Diagnostic Equipment & Supplies
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com